Lidocaine Hydrochloride Topical Solution Recalled for Superpotency
Teligent Pharma is recalling Lidocaine Hydrochloride Topical Solution USP 4% due to superpotency. The affected lot was distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. Superpotency in a topical anesthetic represents a manufacturing deviation that could affect efficacy or safety, but without evidence of actual harm, it falls under moderate severity precautionary recalls.
Plain-English summary
Teligent Pharma, Inc. is recalling Lidocaine Hydrochloride Topical Solution USP, 4% (40 mg/mL), packaged in 50 mL screw cap bottles. The product is a prescription topical anesthetic manufactured by Teligent Pharma, Inc. in Buena, NJ, and distributed by McKesson Corporation dba Sky Packaging. The recall affects 7,176 bottles of lot #15594 with an expiration date of 05/2023.
The product is being recalled due to superpotency. The affected lot was distributed to a wholesaler in Colorado, who further distributed it nationwide in the USA.
Consumers and healthcare providers who have received this product should stop use and contact their healthcare provider with any questions or concerns. The NDC number for the recalled product is 63739-997-64.
The recalled product
- Product
- LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE)
- Brand
- LIDOCAINE HYDROCHLORIDE
- Manufacturer
- Teligent Pharma, Inc.
- Category
- Drug — Topical Anesthetic
- Hazard
- Affected units
- 7,176
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 15594
- Exp Date 05/2023
Distribution
Part of a larger recall action
This product is one of 2 recalled by Teligent Pharma, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · LIDOCAINE HYDROCHLORIDE
- SevereLidocaine Hydrochloride Injection Recalled for Sterility Assurance
FDA (Drugs) · 2026-07-08
- HighSpectra lidocaine ampules recalled over lack of sterility assurance
FDA (Drugs) · 2026-06-10
- HighHuons lidocaine injection recalled nationwide over lack of sterility assurance
FDA (Drugs) · 2026-04-22
- HighHuons lidocaine 2% injection recalled over lack of sterility assurance
FDA (Drugs) · 2026-04-22
- SevereLidocaine injection recalled due to glass particulate matter
FDA (Drugs) · 2023-11-15
Same manufacturer · Teligent Pharma, Inc.
See all →- ModerateDesonide Ointment Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Cream USP 0.1% Recall — Stability Study Discontinuation
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Ointment Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- HighDiflorasone Diacetate Ointment recalled due to discontinued stability studies
FDA (Drugs) · 2022-03-30
- ModerateClobetasol Propionate Cream USP 0.05% Recall for cGMP Deviations
FDA (Drugs) · 2022-03-30
Same hazard · superpotency
See all →- HighAripiprazole 10 mg tablets recalled after testing superpotent in one lot
FDA (Drugs) · 2025-09-24
- ModerateHYDROmorphone Hydrochloride 50 mg Cassettes Recalled for Superpotency
FDA (Drugs) · 2025-04-30
- HighLevothyroxine Sodium Tablets Recalled Nationwide for Potency Variance
FDA (Drugs) · 2024-12-18
- HighLevothyroxine Sodium Tablets Recalled for Subpotent and Superpotent Content
FDA (Drugs) · 2024-12-18
- ModerateTriamcinolone Acetonide Cream USP Recalled for Out-of-Specification Potency Variance
FDA (Drugs) · 2024-11-27